---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-26-001106"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2026-03-18T23:59:59+00:00"
generated_at: "2026-05-15T09:54:02.312254+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Lifeward posts Q4 revenue $5.1M (-33% YoY); enters Oramed deal for oral insulin platform

## Summary
- Q4 revenue $5.1M (-33% YoY); full year $22.0M (-14% YoY). ReWalk exoskeleton sales +20% in Q4.
- Net loss narrowed 65% to $5.3M ($3.60/share) in Q4; full year $19.9M ($17.16/share).
- GAAP gross margin 38.2% in 2025 (non-GAAP 40.9%); operating expenses down 25%.
- Cash $2.2M at Dec 31, 2025; expects up to $47M funding from Oramed upon closing strategic deal.
- Shareholders approved Oramed deal: Lifeward acquires POD oral insulin tech; Oramed gets up to 49.99% equity.

## SEC filing metadata
- accession: 0001178913-26-001106
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2026-03-18T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891326001106/0001178913-26-001106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891326001106/zk2634859.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-26-001106
- JSON: https://secwatch.observer/filing/0001178913-26-001106.json
- Plain text: https://secwatch.observer/filing/0001178913-26-001106.txt

## Key facts
- Earnings Releases
  Lifeward Ltd. reported financial results for the fourth quarter and fiscal year ended December 31, 2025.
  - Period: the fourth quarter and fiscal year ended December 31, 2025
  - Result: reported results
  source text: On March 18, 2026, Lifeward Ltd. (the “Company,” “we” or “us”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1607962/000117891326001106/0001178913-26-001106-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.